COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
The reported incidence of immediate hypersensitivity reactions (IHR) including anaphylaxis after COVID-19 vaccination is 10-fold higher than for other vaccines. Several patient groups are theorized to be at particular risk. Since specific vaccination guidelines for these patients are based on expert...
Main Authors: | Toon Ieven, Martijn Vandebotermet, Lisa Nuyttens, David Devolder, Peter Vandenberghe, Dominique Bullens, Rik Schrijvers |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/2/286 |
Similar Items
-
Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions
by: Dimitra Koumaki, et al.
Published: (2023-11-01) -
Development of Hypersensitivity Reactions After Using Different Oral Iron Preparations
by: Öner Özdemir, et al.
Published: (2018-06-01) -
Diagnostic Evaluation of Hypersensitivity Reactions to Antibiotics in a Large Cohort of Mastocytosis Patients
by: Jesper Jarkvist, et al.
Published: (2023-06-01) -
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
by: Jan Romantowski, et al.
Published: (2021-02-01) -
Immediate hypersensitivity to polyethylene glycols in unrelated products: when standardization in the nomenclature of the components of drugs, cosmetics, and food becomes necessary
by: Vicente Jover Cerdá, et al.
Published: (2019-02-01)